Key result
Mild type 2 diabetes reduces myocardial infarct size by ~26 percentage points vs. controls.
Why the study?
Does mild type 2 diabetes mellitus reduce the susceptibility of the heart to ischemia/reperfusion injury in a rat model?
Does mild type 2 diabetes mellitus reduce the susceptibility of the heart to ischemia/reperfusion injury in a rat model?
Short-term mild type 2 diabetes may induce compensatory cardioprotective mechanisms against ischemia/reperfusion injury through gene expression changes.
Should not change diabetes management in acute MI; hypothesis-generating for cardioprotection in mild type 2 diabetes pending human studies.
Despite clinical studies indicating that diabetic hearts are more sensitive to ischemia/reperfusion injury, experimental data is contradictory. Although mild diabetes prior to ischemia/reperfusion may induce a myocardial adaptation, further research is still needed. Nondiabetic Wistar (W) and type 2 diabetic Goto-Kakizaki (GK) rats (16-week-old) underwent 45 min occlusion of the left anterior descending coronary artery and 24 h reperfusion. The plasma glucose level was significantly higher in diabetic rats compared to the nondiabetics. Diabetes mellitus was associated with ventricular hypertrophy and increased interstitial fibrosis. Inducing myocardial infarction increased the glucose levels in diabetic compared to nondiabetic rats. Furthermore, the infarct size was smaller in GK rats than in the control group. Systolic and diastolic functions were impaired in W + MI and did not reach statistical significance in GK + MI animals compared to the corresponding controls. Among the 125 genes surveyed, 35 genes showed a significant change in expression in GK + MI compared to W + MI rats. Short-term diabetes promotes compensatory mechanisms that may provide cardioprotection against ischemia/reperfusion injury, at least in part, by increased antioxidants and the upregulation of the prosurvival PI3K/Akt pathway, by the downregulation of apoptotic genes, proinflammatory cytokine TNF-α, profibrogenic TGF-β, and hypertrophic marker α-actin-1.
No takes yet. Share an insight, caveat, or question.
Korkmaz‐Icöz et al. (2015) studied Ischemia/Reperfusion Injury in Mild Type 2 Diabetes (n=34). Mild type 2 diabetes (Goto-Kakizaki rat model) with myocardial infarction vs. Nondiabetic Wistar rats with myocardial infarction was evaluated on Myocardial infarct size (infarct zone/area at risk) (p=<0.05). Mild type 2 diabetes significantly reduced myocardial infarct size to 27% compared to 53% in nondiabetic control rats following 45 minutes of ischemia and 24 hours of reperfusion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: